Biomarkers Associating with PARP Inhibitor Benefit in Prostate Cancer in the TOPARP-B TrialSuzanne Carreira, Johann S. de Bono, Cláudia Bertan et al.|Cancer Discovery|2021Cited by 161
Advanced Prostate Cancer with ATM Loss: PARP and ATR InhibitorsAntje Neeb, Johann S. de Bono, Nicolás Herranz et al.|European Urology|2020Cited by 118
Homologous recombination repair status in metastatic prostate cancer by next-generation sequencing and functional immunofluorescenceSara Arce‐Gallego, Joaquı́n Mateo|Cell Reports Medicine|2025Cited by 7
Evaluation of homologous recombination repair status in metastatic prostate cancer by next-generation sequencing and functional tissue-based immunofluorescence assaysSara Arce‐Gallego, Joaquı́n Mateo|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 1